<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00455832</url>
  </required_header>
  <id_info>
    <org_study_id>IRIS Study</org_study_id>
    <nct_id>NCT00455832</nct_id>
  </id_info>
  <brief_title>Influence of Ribavirin and Interferon on Semen Quality, IRIS Study</brief_title>
  <acronym>IRIS</acronym>
  <official_title>Influence of Ribavirin and Interferon on Semen Quality, IRIS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Foundation for Liver Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Foundation for Liver Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to study the effect of peginterferon alpha and ribavirin on
      spermatozoa.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      During and six months after treatment with peginterferon alpha and ribavirin strict use of
      birth control is recommended (the producers advice two reliable forms) for both men and women
      because ribavirin has teratogenic and/or embryo-lethal effects in animal studies.

      In cases of pregnancies during paternal exposure to peginterferon alpha and ribavirin
      elective termination of the pregnancy is usually recommended. However three cases of births
      after paternal exposure are reported with no birth defects. Cases of abnormalities after
      paternal exposure to ribavirin are lacking.

      Also studies on the influence of ribavirin on sperm in human are lacking.

      The aim of this study is to study the effect of peginterferon alpha and ribavirin on
      spermatozoa in men using these medication.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">23</enrollment>
  <condition>Sperm Motility (Focus of Study)</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>peginterferon alpha and ribavirin</intervention_name>
    <description>sperm collection</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Treatment with peginterferon and ribavirin in the presence of a chronic Hepatitis C
             infection

        Exclusion Criteria:

          -  Preexisting semen abnormalities.

          -  Concurrent use of drugs influencing sperm concentration,motility and morphology.

          -  Less then one million spermatozoa/ml in semen at screening.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert J de Knegt, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foundation for Liver Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasmus M C, University Medical Center Rotterdam</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2007</study_first_submitted>
  <study_first_submitted_qc>April 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2007</study_first_posted>
  <last_update_submitted>February 28, 2012</last_update_submitted>
  <last_update_submitted_qc>February 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>sperm chromatin structure integrity</keyword>
  <keyword>sperm concentration</keyword>
  <keyword>sperm motility</keyword>
  <keyword>sperm morphology</keyword>
  <keyword>peginterferon</keyword>
  <keyword>ribavirin</keyword>
  <keyword>hepatitis C</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interferons</mesh_term>
    <mesh_term>Ribavirin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

